SEC 13F Intelligence

Krensavage Asset Management, LLC / BNTX

Krensavage Asset Management, LLC’s Biontech SE Position

Does Krensavage Asset Management, LLC own Biontech SE (BNTX)? Yes — 59.5K shares worth $5M (+2.07% of its 13F portfolio) as of Q1 2026, down from 99.5K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
59.5K
% of Portfolio
+2.07%
Quarters Held
9
currently held

Position History BNTX

Reported value by quarter
Q1 ’24: $11MQ1 ’24Q2 ’24: $11MQ3 ’24: $11MQ3 ’24Q4 ’24: $10MQ1 ’25: $8MQ1 ’25Q2 ’25: $8MQ3 ’25: $8MQ3 ’25Q4 ’25: $9MQ1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202659.5K$5M+2.07%
Q4 202599.5K$9M+3.35%
Q3 202579.4K$8M+3.33%
Q2 202573.4K$8M+4.14%
Q1 202587.6K$8M+4.41%
Q4 202488.7K$10M+5.98%
Q3 202493.6K$11M+6.23%
Q2 2024132.3K$11M+4.88%
Q1 2024120.0K$11M+4.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Krensavage Asset Management, LLC’s full portfolio or all institutional holders of BNTX.